Search

Your search keyword '"Carrozza, L."' showing total 122 results
Start Over Author "Carrozza, L."
122 results on '"Carrozza, L."'

29. PC.01.3 SEVERE ACTIVITY OF INFLAMMATORY BOWEL DISEASE IS A RISK FACTOR FOR SEVERE COVID-19: DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD)

Author

Macaluso, F.S., primary, Giuliano, A., additional, Fries, W., additional, Viola, A., additional, Abbruzzese, A., additional, Cappello, M., additional, Giuffrida, E., additional, Carrozza, L., additional, Privitera, A.C., additional, Magnano, A., additional, Ferracane, C., additional, Scalisi, G., additional, Minissale, M.G., additional, Giangreco, E., additional, Garufi, S., additional, Bertolami, C., additional, Cucinotta, U., additional, Graziano, F., additional, Renna, S., additional, Rizzuto, G., additional, Maida, M., additional, and Orlando, A., additional

Published
2021
Full Text
View/download PDF

36. Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV 2 infection: an IG-IBD study

Author

Bezzio, C., Armuzzi, A., Furfaro, F., Ardizzone, S., Milla, M., Carparelli, S., Orlando, A., Caprioli, F. A., Castiglione, F., Vigano, C., Ribaldone, D. G., Zingone, F., Monterubbianesi, R., Imperatore, N., Festa, S., Daperno, M., Scucchi, L., Ferronato, A., Pastorelli, L., Balestrieri, P., Ricci, C., Cappello, M., Felice, C., Fiorino, G., Saibeni, S., Coppini, F., Alvisi, P., Gerardi, V., Variola, A., Mazzuoli, S., Lenti, M. V., Pugliese, D., Allocca, M., Ferretti, F., Roselli, J., Bossa, F., Giuliano, A., Piazza, N., Manes, G., Sartini, A., Buda, A., Micheli, F., Ciardo, V., Casella, G., Viscido, A., Bodini, G., Casini, V., Soriano, A., Amato, A., Grossi, L., Onali, S., Rottoli, M., Spagnuolo, R., Baroni, S., Cortelezzi, C. C., Baldoni, M., Vernero, M., Scaldaferri, F., Maconi, G., Guarino, A. D., Palermo, A., D'Inca, R., Scribano, M. L., Biancone, L., Carrozza, L., Ascolani, M., Costa, F., Di Sabatino, A., Zammarchi, I., Gottin, M., Conforti, F. S., Bezzio, Cristina, Armuzzi, Alessandro, Furfaro, Federica, Ardizzone, Sandro, Milla, Monica, Carparelli, Sonia, Orlando, Ambrogio, Caprioli, Flavio Andrea, Castiglione, Fabiana, Viganò, Chiara, Ribaldone, Davide Giuseppe, Zingone, Fabiana, Monterubbianesi, Rita, Imperatore, Nicola, Festa, Stefano, Daperno, Marco, Scucchi, Ludovica, Ferronato, Antonio, Pastorelli, Luca, Balestrieri, Paola, Ricci, Chiara, Cappello, Maria, Felice, Carla, Fiorino, Gionata, Saibeni, Simone, and Francesca Coppini, Patrizia Alvisi, Viviana Gerardi, Angela Variola, Silvia Mazzuoli, Marco Vincenzo Lenti, Daniela Pugliese, Mariangela Allocca, Francesca Ferretti, Jenny Roselli, Fabrizio Bossa, Alessandra Giuliano, Nicole Piazza, Gianpiero Manes, Alessandro Sartini, Andrea Buda, Federica Micheli, Valeria Ciardo, Giovanni Casella, Angelo Viscido, Giorgia Bodini, Valentina Casini, Alessandra Soriano, Arnaldo Amato, Laurino Grossi, Sara Onali, Matteo Rottoli, Rocco Spagnuolo, Stefania Baroni, Claudio Cortelezzi, Monia Baldoni, Marta Vernero, Franco Scaldaferri, Giovanni Maconi, Alessia Dalila Guarino, Andrea Palermo, Renata D'Incà, Maria Lia Scribano, Livia Biancone, Lucio Carrozza, Marta Ascolani, Francesco Costa, Antonio Di Sabatino, Irene Zammarchi, Matteo Gottin, Francesco Simone Conforti

Subjects
medicine.medical_specialty, Settore MED/12 - GASTROENTEROLOGIA, IBD, Population, Ulcerative, Disease, Lower risk, Asymptomatic, Inflammatory bowel disease, Aged, Humans, SARS-CoV-2, Tumor Necrosis Factor Inhibitors, COVID-19, Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases, IBD Treatments and Sars‐cov‐2 Infection, Internal medicine, medicine, biologics, Pharmacology (medical), education, therapy, education.field_of_study, Hepatology, business.industry, INFLAMMATORY BOWEL DISEASE, Gastroenterology, medicine.disease, Colitis, Ulcerative colitis, Pneumonia, Original Article, medicine.symptom, business, Cohort study
Abstract

Summary Background Older age and comorbidities are the main risk factors for adverse COVID‐19 outcomes in patients with inflammatory bowel disease (IBD). The impact of IBD medications is still under investigation. Aims To assess risk factors for adverse outcomes of COVID‐19 in IBD patients and use the identified risk factors to build risk indices. Methods Observational cohort study. Univariable and multivariable logistic regression was used to identify risk factors associated with pneumonia, hospitalisation, need for ventilatory support, and death. Results Of the 937 patients (446 with ulcerative colitis [UC]) evaluated, 128 (13.7%) had asymptomatic SARS‐CoV‐2 infection, 664 (70.8%) had a favourable course, and 135 (15.5%) had moderate or severe COVID‐19. In UC patients, obesity, active disease and comorbidities were significantly associated with adverse outcomes. In patients with Crohn's disease (CD), age, obesity, comorbidities and an additional immune‐mediated inflammatory disease were identified as risk factors. These risk factors were incorporated into two indices to identify patients with UC or CD with a higher risk of adverse COVID‐19 outcomes. In multivariable analyses, no single IBD medication was associated with poor COVID‐19 outcomes, but anti‐TNF agents were associated with a lower risk of pneumonia in UC, and lower risks of hospitalisation and severe COVID‐19 in CD. Conclusion The course of COVID‐19 in patients with IBD is similar to that in the general population. IBD patients with active disease and comorbidities are at greater risk of adverse COVID‐19 outcomes. IBD medications do not pose additional risks. The risk indices may help to identify patients who should be prioritised for COVID‐19 re‐vaccination or for therapies for SARS‐CoV‐2 infection., The course of COVID‐19 in patients with IBD patients is similar to that in the general population. IBD patients with active disease and comorbidities are at greater risk of adverse COVID‐19 outcomes. IBD medications do not pose additional risks.

Published
2021

37. T04.01.11 PREVALENCE OF NAFLD (NON ALCOHOLIC FATTY LIVER DISEASE) IN INFLAMMATORY BOWEL DISEASE: THE IMPACT OF TRADITIONAL RISK FACTORS, INTESTINAL INFLAMMATION AND GENETIC PHENOTYPE

Author

Scrivo, B., primary, Celsa, C., additional, Busacca, A., additional, Giuffrida, E., additional, Guida, L., additional, Carrozza, L., additional, Petta, S., additional, Pipitone, R.M., additional, Grimaudo, S., additional, Cammà, C., additional, and Cappello, M., additional

Published
2020
Full Text
View/download PDF

43. Optimal removal time of lumen-apposing metal stent (LAMS) after placement for drainage of pancreatic fluid collections: a systematic review and meta-analysis.

Author

Maida, M., Rizzo, G.E. M., Carrozza, L., Rancatore, G., Ligresti, D., Traina, M., Fabbri, C., Anderloni, A., and Tarantino, I.

Subjects
FLUIDS, RANDOM effects model, ENDOSCOPIC ultrasonography
Abstract

This article, published in the journal Endoscopy, presents a systematic review and meta-analysis on the optimal removal time of lumen-apposing metal stents (LAMS) used for endoscopic ultrasound-guided drainage of pancreatic fluid collections (PFCs). The study aimed to assess the incidence of adverse events (AEs) after early (within 3-4 weeks) versus late (after 3-4 weeks) LAMS removal. The analysis included three studies with a total of 1565 patients, and the results showed that early removal of LAMS was associated with a lower rate of AEs. However, the authors note that more research is needed to provide robust data on this topic. [Extracted from the article]

Published
2024
Full Text
View/download PDF

50. Counseling Utilization Related to Dose Reduction in Methadone Maintenance

Author

Carrozza L, B Walker, Berkson R, V Patch, P Butler, J Morrison, O'Connell R, J Reilly, and Creel S

Subjects
Adult, Counseling, Male, Methadone maintenance, medicine.medical_specialty, Adolescent, Heroin Dependence, business.industry, Addiction, media_common.quotation_subject, education, Administration, Oral, Medicine (miscellaneous), Emergency medicine, Humans, Medicine, Female, Dose reduction, business, Methadone, Stress, Psychological, health care economics and organizations, Boston, media_common
Abstract

(1974). Counseling Utilization Related to Dose Reduction in Methadone Maintenance. International Journal of the Addictions: Vol. 9, No. 6, pp. 841-849.

Published
1974

Catalog

Books, media, physical & digital resources
See catalog results